Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

spaXio · Spatial Crosstalk in Immuno-Oncology

HORIZONStatus: SIGNED1 October 202530 September 2030EU funding €4,393,218Call HORIZON-MSCA-2024-DN-01

Metastasis, the leading cause of cancer-related deaths, arises from the spread of cancer cells to distant organs, where they compromise normal organ function. Cellular interactions, paracrine factors, and the metabolic environment promote the formation of metastatic niches that facilitate tumour cell survival and proliferation. While single-cell data have improved our understanding of tumours and their heterogeneity, our knowledge of metastatic niches is still very incomplete. In particular, the lack of spatial context makes it difficult to address critical knowledge gaps in metastatic niche biology which limits our progress in the development of targeted therapeutic interventions.The doctoral network spaXio aims to tackle this challenge by training doctoral candidates (DCs) in cutting-edge techniques, including spatially resolved multi-omics, advanced tumoroid modelling, and computational approaches, including bioinformatics and AI-based prediction models. DCs will conduct systemic analyses of metastatic niches across diverse organ systems and tumour types to improve our understanding of metastatic niche formation and uncover novel therapeutic targets. SpaXio provides comprehensive, multidisciplinary training that combines hands-on laboratory experience, computational data integration, and (industry) secondments. Regular cross-disciplinary workshops and seminars boost innovation and collaboration, while transferable skills training encompasses communication, ethical research, open science, entrepreneurship, and sustainability. By partnering with a network of leading European and international academic, clinical, and industrial experts, spaXio ensures that DCs are exposed to diverse research environments and approaches. This fosters their ability to think across borders, advance technologies and integrate multiple large datasets into a complete systemic picture, preparing them to be leaders in cancer research and shape the rapidly evolving field of spatial biology.

Consortium · 19 organisations

coordinator

PARIS-LODRON-UNIVERSITAT SALZBURG

AT · €1,210,172

associatedPartner

Waters GmbH

DE

associatedPartner

MILTENYI BIOTEC BV & CO KG

DE

associatedPartner

Okomera

FR

associatedPartner

10X GENOMICS, INC.

US

participant

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

FR · €419,559

associatedPartner

UNIVERSITE DE LAUSANNE

CH

participant

TECHNISCHE UNIVERSITAET MUENCHEN

DE · €387,030

associatedPartner

Molecular Devices (Austria) GmbH

AT

associatedPartner

PHASICS SA

FR

associatedPartner

CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS

CH

participant

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

ES · €376,251

participant

DEEPLIFE

FR · €419,559

associatedPartner

PROTISVALOR MEDITERRANEE SAS

FR

associatedPartner

Akoya Biosciences, Inc.

US

participant

UNIVERSITE D'AIX MARSEILLE

FR · €419,559

associatedPartner

SUMO TECHNOLOGIES GMBH

AT

participant

EBERHARD KARLS UNIVERSITAET TUEBINGEN

DE · €1,161,089

associatedPartner

UNIVERSIDAD AUTONOMA DE MADRID

ES

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.